Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000018.xml
Facial Plast Surg 2017; 33(06): 621-626
DOI: 10.1055/s-0037-1607446
DOI: 10.1055/s-0037-1607446
Original Article
Scar Revision: Surgical and Nonsurgical Options
Further Information
Publication History
Publication Date:
01 December 2017 (online)
![](https://www.thieme-connect.de/media/fps/201706/lookinside/thumbnails/10-1055-s-0037-1607446_170048oa-1.jpg)
Abstract
Facial scarring represents a challenging issue for the facial plastic surgeon owing to the unpredictable and variable nature of scar formation. The psychologic, cosmetic, and functional implications of facial scars oftentimes necessitate revision. It is important for the facial plastic surgeon to be aware of the invasive and noninvasive options to best educate patients in terms of treatment modalities. As there are multiple options available with no single option touted as superior, management of expectations and patient motivation will allow for realistic treatment planning with the greatest change of success.
-
References
- 1 Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 2008; 32 (01) 82-92
- 2 Mustoe TA, Cooter RD, Gold MH. , et al; International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110 (02) 560-571
- 3 Monstrey S, Middelkoop E, Vranckx JJ. , et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 2014; 67 (08) 1017-1025
- 4 Carney SA, Cason CG, Gowar JP. , et al. Cica-Care gel sheeting in the management of hypertrophic scarring. Burns 1994; 20 (02) 163-167
- 5 Gold MH, Berman B, Clementoni MT, Gauglitz GG, Nahai F, Murcia C. Updated international clinical recommendations on scar management: part 1--evaluating the evidence. Dermatol Surg 2014; 40 (08) 817-824
- 6 Gold MH, McGuire M, Mustoe TA. , et al; International Advisory Panel on Scar Management. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg 2014; 40 (08) 825-831
- 7 O'Brien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2006; (01) CD003826
- 8 Chuangsuwanich A, Gunjittisomram S. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids. J Med Assoc Thai 2007; 90 (07) 1363-1367
- 9 Viera MH, Vivas AC, Berman B. Update on keloid management: clinical and basic science advances. Adv Wound Care (New Rochelle) 2012; 1 (05) 200-206
- 10 Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 2004; 12 (05) 546-556
- 11 Hayashi T, Furukawa H, Oyama A. , et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg 2012; 38 (06) 893-897
- 12 Fang QQ, Chen CY, Zhang MX. , et al. The effectiveness of topical anti-scarring agents and a novel combined process on cutaneous scar management. Curr Pharm Des 2016; 23 (15) 2268-2275
- 13 Saray Y, Güleç AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol 2005; 44 (09) 777-784
- 14 Shah VV, Aldahan AS, Mlacker S, Alsaidan M, Samarkandy S, Nouri K. 5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther (Heidelb) 2016; 6 (02) 169-183
- 15 Lighthall JG, Fedok FG. Treating scars of the chin and perioral region. Facial Plast Surg Clin North Am 2017; 25 (01) 55-71
- 16 Agarwal J, Kadakia S, Saman M. Current concepts in dermabrasion therapy. Am J Cosmet Surg 2016; 33 (03) 140-144
- 17 Gold MH. Dermabrasion in dermatology. Am J Clin Dermatol 2003; 4 (07) 467-471
- 18 Yarborough Jr JM. Ablation of facial scars by programmed dermabrasion. J Dermatol Surg Oncol 1988; 14 (03) 292-294
- 19 Brenner MJ, Perro CA. Recontouring, resurfacing, and scar revision in skin cancer reconstruction. Facial Plast Surg Clin North Am 2009; 17 (03) 469-487.e3
- 20 Wu EC, Wong BJ. Lasers and optical technologies in facial plastic surgery. Arch Facial Plast Surg 2008; 10 (06) 381-390
- 21 Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34 (05) 426-438
- 22 Tidwell WJ, Owen CE, Kulp-Shorten C, Maity A, McCall M, Brown TS. Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: results of a split scar, double blinded, prospective trial. Lasers Surg Med 2016; 48 (09) 837-843
- 23 Brauer JA, Patel U, Hale EK. Laser skin resurfacing, chemical peels, and other cutaneous treatments of the brow and upper lid. Clin Plast Surg 2013; 40 (01) 91-99
- 24 Chiu LL, Sun CH, Yeh AT. , et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med 2005; 37 (03) 231-244
- 25 Ud-Din S, Thomas G, Morris J, Bayat A. Photodynamic therapy: an innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools. Arch Dermatol Res 2013; 305 (03) 205-214
- 26 Sakamoto FH, Izikson L, Tannous Z, Zurakowski D, Anderson RR. Surgical scar remodelling after photodynamic therapy using aminolaevulinic acid or its methyl ester: a retrospective, blinded study of patients with field cancerization. Br J Dermatol 2012; 166 (02) 413-416
- 27 Mamalis AD, Lev-Tov H, Nguyen DH, Jagdeo JR. Laser and light-based treatment of keloids--a review. J Eur Acad Dermatol Venereol 2014; 28 (06) 689-699
- 28 Watson D, Reuther MS. Scar revision techniques-pearls and pitfalls. Facial Plast Surg 2012; 28 (05) 487-491
- 29 Song C, Wu HG, Chang H, Kim IH, Ha SW. Adjuvant single-fraction radiotherapy is safe and effective for intractable keloids. J Radiat Res (Tokyo) 2014; 55 (05) 912-916
- 30 Jiang P, Baumann R, Dunst J. , et al. Perioperative interstitial high-dose-rate brachytherapy for the treatment of recurrent keloids: feasibility and early results. Int J Radiat Oncol Biol Phys 2016; 94 (03) 532-536
- 31 Mankowski P, Kanevsky J, Tomlinson J, Dyachenko A, Luc M. Optimizing radiotherapy for keloids: a meta-analysis systematic review comparing recurrence rates between different radiation modalities. Ann Plast Surg 2017; 78 (04) 403-411